We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
-6.06%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.43B
AUM Growth
-$165M
Cap. Flow
-$57.4M
Cap. Flow %
-4.01%
Top 10 Hldgs %
25.47%
Holding
484
New
55
Increased
94
Reduced
160
Closed
54

Sector Composition

1 Healthcare 30.56%
2 Consumer Staples 25.79%
3 Communication Services 7.82%
4 Materials 7.12%
5 Technology 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
1
Merck
MRK
$315B
$41.1M 2.87%
477,311
-496
-0.1% -$44.3K
PFE icon
2
Pfizer
PFE
$143B
$40.9M 2.86%
934,407
+49,309
+6% +$2.4M
GIS icon
3
General Mills
GIS
$20.7B
$40.2M 2.81%
524,140
-70,452
-12% -$5.37M
KMB icon
4
Kimberly-Clark
KMB
$36.2B
$37.4M 2.61%
331,962
+8,666
+3% +$1.13M
K
5
DELISTED
Kellanova
K
$36.4M 2.55%
556,952
-50,366
-8% -$3.46M
CLX icon
6
Clorox
CLX
$11.9B
$34.8M 2.43%
270,666
-17,732
-6% -$2.56M
HRL icon
7
Hormel Foods
HRL
$14.1B
$34.1M 2.38%
750,605
-45,493
-6% -$2.2M
SJM icon
8
J.M. Smucker
SJM
$12.2B
$33.5M 2.34%
243,702
-46,041
-16% -$6.27M
CHD icon
9
Church & Dwight Co
CHD
$23.5B
$33.5M 2.34%
468,378
+81,102
+21% +$7M
GEN icon
10
Gen Digital
GEN
$16.3B
$32.6M 2.28%
1,619,430
-30,687
-2% -$710K
DGX icon
11
Quest Diagnostics
DGX
$23.2B
$31.9M 2.23%
259,843
+491
+0.2% +$64.7K
BIIB icon
12
Biogen
BIIB
$30.8B
$31.8M 2.22%
119,064
-42,789
-26% -$9.09M
CHRW icon
13
C.H. Robinson
CHRW
$24.3B
$31.3M 2.18%
324,469
-29,294
-8% -$3.15M
CPB icon
14
Campbell Soup
CPB
$6.75B
$30.8M 2.15%
654,212
-32,362
-5% -$1.59M
NBIX icon
15
Neurocrine Biosciences
NBIX
$17.2B
$30.5M 2.13%
286,871
-19,623
-6% -$1.99M
LLY icon
16
Eli Lilly
LLY
$1.04T
$29.8M 2.08%
92,099
-18,551
-17% -$5.88M
NEM icon
17
Newmont
NEM
$97B
$29.6M 2.07%
705,248
+190,002
+37% +$8.88M
DLTR icon
18
Dollar Tree
DLTR
$24.7B
$27.7M 1.94%
203,805
+26,342
+15% +$4.1M
BAX icon
19
Baxter International
BAX
$12.1B
$26.8M 1.87%
497,234
+179,001
+56% +$10.8M
BDX icon
20
Becton Dickinson
BDX
$44.1B
$26.7M 1.86%
119,704
-33,517
-22% -$8.34M
AIZ icon
21
Assurant
AIZ
$13.6B
$24.6M 1.72%
169,426
+46,406
+38% +$7.58M
ES icon
22
Eversource Energy
ES
$28.2B
$22.6M 1.58%
290,098
+83,047
+40% +$7.32M
ED icon
23
Consolidated Edison
ED
$41.4B
$22.3M 1.56%
260,041
-36,117
-12% -$3.48M
AEM icon
24
Agnico Eagle Mines
AEM
$68.6B
$20.2M 1.41%
476,284
+25,180
+6% +$1.08M
ALNY icon
25
Alnylam Pharmaceuticals
ALNY
$37.8B
$20.2M 1.41%
100,865
-79,236
-44% -$15.1M

Similar funds

TOBAM's Q3 2022 Portfolio in Review

As of Q3 2022, TOBAM held 484 positions worth $1.43B, down 10% from $1.6B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

TOBAM withdrew a net $57.4M in Q3 2022, closing 54 positions and reducing 160 holdings. Its most notable exit was Lyft, an estimated $9.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 28% a quarter earlier, followed by Consumer Staples and Communication Services.

Against the trend, TOBAM opened a new position in argenx worth $6.16M.

  • TOBAM's largest Q3 2022 buy was argenx: 17,439 shares worth $6.16M.
  • TOBAM added most to DaVita in Q3 2022, an estimated $12.2M increase.
  • TOBAM's biggest Q3 2022 reduction was Electronic Arts, cutting an estimated $17.2M.
  • TOBAM fully exited Lyft in Q3 2022, selling an estimated $9.44M.
  • TOBAM's ten largest holdings make up 25% of its $1.43B portfolio in Q3 2022.
  • TOBAM opened 55 new positions and closed 54 in Q3 2022.
  • TOBAM's portfolio value fell 10% quarter-over-quarter to $1.43B.

Based on TOBAM's 13F filing for Q3 2022, filed 2 Nov 2022.